• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

MYR

edit

MYR GmbH is a Burgwedel (Hannover), Germany-based biotech company that develops a drug for the treatment of chronic hepatitis B and D infections.

Milestones

edit

• 
  MYR received $708k (€500k) in Venture Round funding. (5/12/11)
  Posted 5/12/11 at 8:15pm via finsmes.com
• 
  MYR — German-Russian Biomedical Companies Hepatera And MYR Receive Monetary Booster (4/12/12)
  Posted 4/13/12 at 1:44pm via invest-iq.net

Videos

Screenshots

edit

Sources

1. MYR Receives €500K Equity Investment from High-Tech Gründerfonds (finsmes.com) [edit]
German-Russian Biomedical Companies Hepatera And MYR Receive Monetary Booster (invest-iq.net) [edit]